Artwork

コンテンツは Subhi Saadeh によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Subhi Saadeh またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

135 - Combination Products Mindset, MDUFA and Combination Products, FDA Hierarchy, Supplier Management, Surprises in Industry, and Culture with Tony Watson

41:16
 
シェア
 

Manage episode 417107973 series 3325357
コンテンツは Subhi Saadeh によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Subhi Saadeh またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

On this episode, I was joined by Tony Watson, Vice President of Regulatory and Quality at Windgap Medical.

On this episode, Anthony discusses:

03:11 The Formation and Impact of the Office of Combination Products

04:16 Challenges and Changes in the Regulatory Landscape for Combination Products

07:53 Understanding FDA Titles and Organizational Structure

11:03 From FDA to Biogen: Transitioning to Industry and Building Medical Device Competency

16:41 Insights into FDA and Industry Dynamics: Conferences, Regulations, and Mindset Shifts

20:05 Combination Product Mindset in Large Organizations vs. Startups

21:54 Navigating Small Company Dynamics and Supply Chain Management

22:29 The Importance of a Combination Product Mindset

25:14 Challenges and Evolution of Combination Products

26:42 Global Perspectives on Combination Products

27:30 Digital Health: The New Frontier

35:02 Quality Culture and Open Communication

Anthony started his career as a naval officer on ships before transitioning to the civilian side of government. He served nearly 20 years at FDA as a reviewer, branch chief, and division director. In his time at FDA, he was one of the original regulatory policy-makers for combination products on the CDRH side. He has led the development of sevral guidance documents that are still in use more than 10 years after he left FDA. He has been active in industry advocay groups and standards efforts related to combination products for nearly 20 years. Since leaving FDA in 2013, Anthony has been developing and leading device and combination product teams in biotech, biopharma, and digital health companies from startups to global scale. He is presently the Vice President of Regulatory Affairs and Quality at Windgap Medical, a drug delivery device startup in Watertown, Massachusetts. He is also an adjunct professor at Northeastern University in the Regulatory Affairs Program and advises companies in the digital health field.

LinkedIn url: https://www.linkedin.com/in/anthony-w-77abaa3?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=android_app

  continue reading

142 つのエピソード

Artwork
iconシェア
 
Manage episode 417107973 series 3325357
コンテンツは Subhi Saadeh によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Subhi Saadeh またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

On this episode, I was joined by Tony Watson, Vice President of Regulatory and Quality at Windgap Medical.

On this episode, Anthony discusses:

03:11 The Formation and Impact of the Office of Combination Products

04:16 Challenges and Changes in the Regulatory Landscape for Combination Products

07:53 Understanding FDA Titles and Organizational Structure

11:03 From FDA to Biogen: Transitioning to Industry and Building Medical Device Competency

16:41 Insights into FDA and Industry Dynamics: Conferences, Regulations, and Mindset Shifts

20:05 Combination Product Mindset in Large Organizations vs. Startups

21:54 Navigating Small Company Dynamics and Supply Chain Management

22:29 The Importance of a Combination Product Mindset

25:14 Challenges and Evolution of Combination Products

26:42 Global Perspectives on Combination Products

27:30 Digital Health: The New Frontier

35:02 Quality Culture and Open Communication

Anthony started his career as a naval officer on ships before transitioning to the civilian side of government. He served nearly 20 years at FDA as a reviewer, branch chief, and division director. In his time at FDA, he was one of the original regulatory policy-makers for combination products on the CDRH side. He has led the development of sevral guidance documents that are still in use more than 10 years after he left FDA. He has been active in industry advocay groups and standards efforts related to combination products for nearly 20 years. Since leaving FDA in 2013, Anthony has been developing and leading device and combination product teams in biotech, biopharma, and digital health companies from startups to global scale. He is presently the Vice President of Regulatory Affairs and Quality at Windgap Medical, a drug delivery device startup in Watertown, Massachusetts. He is also an adjunct professor at Northeastern University in the Regulatory Affairs Program and advises companies in the digital health field.

LinkedIn url: https://www.linkedin.com/in/anthony-w-77abaa3?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=android_app

  continue reading

142 つのエピソード

すべてのエピソード

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド